Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group.
In order to investigate whether plasma microRNA-33a (miR-33a) can be a biomarker for the early detection of atherosclerosis and to reexamine the assumption that miR-33a represses the expression of ABCA1, we compared the expression levels of miR-33a and ATP-binding cassette A1 (ABCA1) using human plasma and supernatants of macrophage cultured media. We first separated ample number of plasma samples from left-over whole blood samples based on the criteria for normal or dyslipidemia, and stored them at -20 °C until use. Then we selected 18 plasma samples for each normal, athero-risk and treated group using a metabolic disease cohort in which candidate subjects have participated. For classifying into three groups, we primarily relied on the records of physicians' comments, prescriptions, treatment history, lipid profiles and test results from medical equipment aimed at the diagnosis for atherosclerosis or cardiovascular disease. After collecting the final 54 plasma samples, we analyzed and compared the expression levels of miR-33a and ABCA1 at the plasma levels. In the comparison of plasma levels of the three groups, the miR-33a expression level of athero-risk group was 5.01-fold higher than that of normal group. Meanwhile, in the culture of foam cells transfected with anti-miR-33a oligonucleotides, the miR-33a level significantly decreased, while ABCA1 level significantly increased. The results suggest that enhanced expression of miR-33a might induce cholesterol accumulation and aggravate inflammation in vessel walls by suppressing the expression of ABCA1 in macrophages. Thus, plasma miR-33a can be considered as a candidate biomarker of atherosclerosis.
Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Hana Science Hall, Anam-Ro 145, Sungbuk-Gu, Seoul, 02841, South Korea.|Department of Biomedical Laboratory Science, Gimcheon University, 214 Daehak-ro, Gimcheon City, Gyeongsangbuk-Do, 39528, South Korea.
Soo Hwan
SH
Kim
Placenta Research Laboratory, Department of Biomedical Science, CHA University, 335 PanGyo-Ro, BunDang-Gu, SungNam-si, GyungGi-Do, 13488, South Korea.
Gi Jin
GJ
Kim
Faculty of Medical Sciences, Department of Health Sciences, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka, 812-8582, Japan.|Department of Medical Technology and Sciences, International University of Health and Welfare, Enokizu 137-1, Ohkawa City, Fukuoka, 831-8501, Japan.
Tsukuru
T
Umemura
Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Hana Science Hall, Anam-Ro 145, Sungbuk-Gu, Seoul, 02841, South Korea.|Faculty of Health and Environmental Science, College of Health Science, Korea University, Hana Science Hall, Anam-Ro 145, Sungbuk-Gu, Seoul, 02841, South Korea.
Seung Gwan
SG
Lee
Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Hana Science Hall, Anam-Ro 145, Sungbuk-Gu, Seoul, 02841, South Korea. chokj@korea.ac.kr.|Faculty of Health and Environmental Science, College of Health Science, Korea University, Hana Science Hall, Anam-Ro 145, Sungbuk-Gu, Seoul, 02841, South Korea. chokj@korea.ac.kr.
Kyung Jin
KJ
Cho
D064286:ATP Binding Cassette Transporter 1 / Q000097:blood*; D050197:Atherosclerosis / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D018929:Cell Culture Techniques; D002454:Cell Differentiation; D002478:Cells, Cultured; D042241:Early Diagnosis; D005487:Foam Cells / Q000166:cytology; D015870:Gene Expression; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D006801:Humans; D035683:MicroRNAs / Q000097:blood*
C577836:ABCA1 protein, human; D064286:ATP Binding Cassette Transporter 1; C550416:MIRN33a microRNA, human; D035683:MicroRNAs
ABCA1; Atherosclerosis; Foam cells; MiRNA-33a; MicroRNA oligonucleotides; Plasma biomarker
Nat Cell Biol. 2011 Apr;13(4):423-33
21423178
Atherosclerosis. 2016 Mar;246:352-60
26828754
J Clin Invest. 2011 Jul;121(7):2921-31
21646721
Cardiovasc Res. 2012 Mar 15;93(4):633-44
22258631
Diabetes. 2012 Mar;61(3):653-8
22315319
Science. 2010 Jun 18;328(5985):1570-3
20466885
Circ Res. 2012 Feb 3;110(3):483-95
22302755
Indian Pediatr. 2011 Apr;48(4):277-87
21532099
J Biol Chem. 2009 Nov 20;284(47):32336-43
19783654
Cell Res. 2008 Oct;18(10):997-1006
18766170
Mol Cell Biol. 2013 Jun;33(11):2339-52
23547260
Thromb Haemost. 2012 Apr;107(4):642-7
22274626
Mediators Inflamm. 2012;2012:693083
22577254
PLoS One. 2014 Apr 14;9(4):e94997
24733347
PLoS One. 2014 Oct 17;9(10 ):e109722
25329888
Nat Rev Immunol. 2013 Oct;13(10):709-21
23995626
Mol Med. 2012 Mar 27;18:149-58
22064972
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):178-85
23325474
J Am Heart Assoc. 2012 Dec;1(6):e003376
23316322
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9232-7
21576456
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12228-32
20566875
Nature. 2011 Oct 19;478(7369):404-7
22012398
Science. 2010 Jun 18;328(5985):1566-9
20466882
J Clin Invest. 2002 Jul;110(1):35-42
12093886
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2378-82
22011750
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):239-50
22436747
Circ Res. 2010 Sep 3;107(5):677-84
20595655
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
18663219
Molecules. 2014 Jan 27;19(2):1568-75
24473213